IL149755A0 - N-[5-[[[5-alkyl-2 oxazolyl] methyl]thio]-2-thiazolyl] carboxamide derivatives and pharmaceutical compositions containing the same - Google Patents

N-[5-[[[5-alkyl-2 oxazolyl] methyl]thio]-2-thiazolyl] carboxamide derivatives and pharmaceutical compositions containing the same

Info

Publication number: IL149755A0
Authority: IL; Israel
Prior art keywords: oxazolyl; thiazolyl; thio; alkyl; methyl
Prior art date: 1999-12-15

Application number

IL14975500A

Other languages

English (en)

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-15

Filing date

2000-12-07

Publication date

2002-12-01

1999-12-15 Priority claimed from US09/464,511 external-priority patent/US6262096B1/en

2000-12-07 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2002-12-01 Publication of IL149755A0 publication Critical patent/IL149755A0/xx

Links

229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
125000002971 oxazolyl group Chemical group 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
125000000446 sulfanediyl group Chemical group *S* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Immunology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL14975500A 1999-12-15 2000-12-07 N-[5-[[[5-alkyl-2 oxazolyl] methyl]thio]-2-thiazolyl] carboxamide derivatives and pharmaceutical compositions containing the same IL149755A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US09/464,511 US6262096B1 (en)	1997-11-12	1999-12-15	Aminothiazole inhibitors of cyclin dependent kinases
US61662700A	2000-07-26	2000-07-26
PCT/US2000/033501 WO2001044242A1 (en)	1999-12-15	2000-12-07	N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases

Publications (1)

Publication Number	Publication Date
IL149755A0 true IL149755A0 (en)	2002-12-01

Family

ID=27041008

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14975500A IL149755A0 (en)	1999-12-15	2000-12-07	N-[5-[[[5-alkyl-2 oxazolyl] methyl]thio]-2-thiazolyl] carboxamide derivatives and pharmaceutical compositions containing the same
IL149755A IL149755A (en)	1999-12-15	2002-05-20	History of N–] 5 -]]] - 5– Alkyl – 2– Oxazolil [Methyl [thio [–2 – thiazolil] Carboxamide and pharmaceutical preparations containing them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL149755A IL149755A (en)	1999-12-15	2002-05-20	History of N–] 5 -]]] - 5– Alkyl – 2– Oxazolil [Methyl [thio [–2 – thiazolil] Carboxamide and pharmaceutical preparations containing them

Country Status (29)

Country	Link
EP (1)	EP1240166B1 (cs)
JP (1)	JP2003516987A (cs)
KR (1)	KR100738132B1 (cs)
CN (1)	CN1433416A (cs)
AR (1)	AR026974A1 (cs)
AT (1)	ATE289306T1 (cs)
AU (1)	AU783719B2 (cs)
BR (1)	BR0016424A (cs)
CA (1)	CA2394552A1 (cs)
CO (1)	CO5261565A1 (cs)
CZ (1)	CZ20022015A3 (cs)
DE (1)	DE60018205T2 (cs)
DK (1)	DK1240166T3 (cs)
EG (1)	EG24168A (cs)
ES (1)	ES2236034T3 (cs)
HK (1)	HK1049661B (cs)
HU (1)	HUP0301032A3 (cs)
IL (2)	IL149755A0 (cs)
MX (1)	MXPA02005870A (cs)
MY (1)	MY125768A (cs)
NO (1)	NO323726B1 (cs)
NZ (1)	NZ519120A (cs)
PE (1)	PE20011026A1 (cs)
PL (1)	PL364921A1 (cs)
PT (1)	PT1240166E (cs)
RU (1)	RU2002119016A (cs)
TW (1)	TWI273103B (cs)
UY (1)	UY26481A1 (cs)
WO (1)	WO2001044242A1 (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6262096B1 (en)	1997-11-12	2001-07-17	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases
US6414156B2 (en) *	1998-10-21	2002-07-02	Bristol-Myers Squibb Company	Process for preparing azacycloalkanoylaminothiazoles
US6515004B1 (en)	1999-12-15	2003-02-04	Bristol-Myers Squibb Company	N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
US6392053B2 (en)	1999-12-15	2002-05-21	Bristol-Myers Squibb Company	Process for preparing arylacetylaminothiazoles
WO2002010162A1 (en) *	2000-07-26	2002-02-07	Bristol-Myers Squibb Company	N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
AU2001290912A1 (en)	2000-09-15	2002-03-26	Vertex Pharmaceuticals Incorporated	Pyrazole compounds useful as protein kinase inhibitors
US7473691B2 (en)	2000-09-15	2009-01-06	Vertex Pharmaceuticals Incorporated	Pyrazole compounds useful as protein kinase inhibitors
US6660731B2 (en)	2000-09-15	2003-12-09	Vertex Pharmaceuticals Incorporated	Pyrazole compounds useful as protein kinase inhibitors
BR0116493A (pt)	2000-12-21	2003-09-30	Vertex Pharma	Compostos de pirazol úteis como inibidores de proteìna cinase
MY141867A (en)	2002-06-20	2010-07-16	Vertex Pharma	Substituted pyrimidines useful as protein kinase inhibitors
MXPA05001367A (es)	2002-08-02	2005-04-28	Vertex Pharma	Composiciones de pirazol utiles como inhibidores de gsk-3.
US7392929B1 (en)	2004-07-26	2008-07-01	Zephyros, Inc.	Weldable synthetic material
EP1845973B1 (en)	2005-01-21	2015-08-12	Astex Therapeutics Limited	Pharmaceutical compounds
DE102005008310A1 (de) *	2005-02-17	2006-08-24	Schering Ag	Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
JP5249770B2 (ja)	2005-11-03	2013-07-31	バーテックスファーマシューティカルズインコーポレイテッド	キナーゼインヒビターとして有用なアミノピリジン
US8883790B2 (en)	2006-10-12	2014-11-11	Astex Therapeutics Limited	Pharmaceutical combinations
US8916552B2 (en)	2006-10-12	2014-12-23	Astex Therapeutics Limited	Pharmaceutical combinations
US8236128B2 (en)	2006-10-26	2012-08-07	Zephyros, Inc.	Adhesive materials, adhesive parts formed therewith and their uses
US20100247552A1 (en) *	2006-11-10	2010-09-30	Massachusetts Institute Of Technology	Pak modulators
WO2010033045A1 (en) *	2008-09-16	2010-03-25	Igor Anatolievich Pomytkin	Compositions and methods for prevention or treatment of beta amyloid deposition
EP2937345B1 (en)	2009-12-29	2018-03-21	Dana-Farber Cancer Institute, Inc.	Type ii raf kinase inhibitors
US10870651B2 (en)	2014-12-23	2020-12-22	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinase 7 (CDK7)
CN107427521B (zh)	2015-03-27	2021-08-03	达纳-法伯癌症研究所股份有限公司	细胞周期蛋白依赖性激酶的抑制剂
WO2017044858A2 (en)	2015-09-09	2017-03-16	Dana-Farber Cancer Institute, Inc.	Inhibitors of cyclin-dependent kinases
EP3810132A4 (en)	2018-06-25	2022-06-22	Dana-Farber Cancer Institute, Inc.	TAIRE FAMILY KINASE INHIBITORS AND RELATED USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6040321A (en) *	1997-11-12	2000-03-21	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases

2000
- 2000-11-16 MY MYPI20005385A patent/MY125768A/en unknown
- 2000-12-07 NZ NZ519120A patent/NZ519120A/en unknown
- 2000-12-07 AT AT00990204T patent/ATE289306T1/de not_active IP Right Cessation
- 2000-12-07 EP EP00990204A patent/EP1240166B1/en not_active Expired - Lifetime
- 2000-12-07 BR BR0016424-0A patent/BR0016424A/pt not_active Application Discontinuation
- 2000-12-07 MX MXPA02005870A patent/MXPA02005870A/es active IP Right Grant
- 2000-12-07 HU HU0301032A patent/HUP0301032A3/hu unknown
- 2000-12-07 CZ CZ20022015A patent/CZ20022015A3/cs unknown
- 2000-12-07 JP JP2001544732A patent/JP2003516987A/ja not_active Withdrawn
- 2000-12-07 CN CN00818900A patent/CN1433416A/zh active Pending
- 2000-12-07 KR KR1020027007615A patent/KR100738132B1/ko not_active Expired - Fee Related
- 2000-12-07 HK HK03100935.5A patent/HK1049661B/en not_active IP Right Cessation
- 2000-12-07 RU RU2002119016/04A patent/RU2002119016A/ru unknown
- 2000-12-07 CA CA002394552A patent/CA2394552A1/en not_active Abandoned
- 2000-12-07 DK DK00990204T patent/DK1240166T3/da active
- 2000-12-07 DE DE60018205T patent/DE60018205T2/de not_active Expired - Fee Related
- 2000-12-07 AU AU27264/01A patent/AU783719B2/en not_active Ceased
- 2000-12-07 IL IL14975500A patent/IL149755A0/xx unknown
- 2000-12-07 PL PL00364921A patent/PL364921A1/xx not_active Application Discontinuation
- 2000-12-07 PT PT00990204T patent/PT1240166E/pt unknown
- 2000-12-07 WO PCT/US2000/033501 patent/WO2001044242A1/en not_active Ceased
- 2000-12-07 ES ES00990204T patent/ES2236034T3/es not_active Expired - Lifetime
- 2000-12-09 EG EG20001523A patent/EG24168A/xx active
- 2000-12-14 UY UY26481A patent/UY26481A1/es not_active Application Discontinuation
- 2000-12-14 CO CO00095237A patent/CO5261565A1/es not_active Application Discontinuation
- 2000-12-14 TW TW089126788A patent/TWI273103B/zh not_active IP Right Cessation
- 2000-12-15 PE PE2000001347A patent/PE20011026A1/es not_active Application Discontinuation
- 2000-12-15 AR ARP000106680A patent/AR026974A1/es unknown
2002
- 2002-05-20 IL IL149755A patent/IL149755A/en active IP Right Grant
- 2002-06-13 NO NO20022817A patent/NO323726B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO20022817L (no)	2002-08-14
DK1240166T3 (da)	2005-06-20
CA2394552A1 (en)	2001-06-21
EP1240166A1 (en)	2002-09-18
PE20011026A1 (es)	2001-12-02
NZ519120A (en)	2004-03-26
PT1240166E (pt)	2005-07-29
MXPA02005870A (es)	2003-01-28
IL149755A (en)	2009-09-22
KR20020067546A (ko)	2002-08-22
AR026974A1 (es)	2003-03-05
ATE289306T1 (de)	2005-03-15
AU2726401A (en)	2001-06-25
EP1240166B1 (en)	2005-02-16
DE60018205D1 (en)	2005-03-24
WO2001044242A9 (en)	2001-11-08
RU2002119016A (ru)	2004-01-10
JP2003516987A (ja)	2003-05-20
NO20022817D0 (no)	2002-06-13
DE60018205T2 (de)	2006-02-16
UY26481A1 (es)	2001-07-31
HUP0301032A3 (en)	2009-03-30
WO2001044242A1 (en)	2001-06-21
KR100738132B1 (ko)	2007-07-10
ES2236034T3 (es)	2005-07-16
TWI273103B (en)	2007-02-11
HUP0301032A2 (hu)	2003-08-28
HK1049661A1 (en)	2003-05-23
PL364921A1 (en)	2004-12-27
CO5261565A1 (es)	2003-03-31
EG24168A (en)	2008-09-10
HK1049661B (en)	2005-10-07
BR0016424A (pt)	2002-08-20
AU783719B2 (en)	2005-12-01
NO323726B1 (no)	2007-07-02
CZ20022015A3 (cs)	2003-02-12
CN1433416A (zh)	2003-07-30
MY125768A (en)	2006-08-30

Publication	Publication Date	Title
IL147939A0 (en)	2002-08-14	Oxazole and thiazole derivatives and pharmaceutical compositions containing the same
IL153591A0 (en)	2003-07-06	N-[5-(((5-alkyl-2-oxazolyl) methyl) thio)-2-thiazolyl] carboxamide and pharmaceutical compositions containing the same
IL149757A0 (en)	2002-12-01	Aminothiazole derivatives and pharmaceutical compositions containing the same
PL352282A1 (en)	2003-08-11	Derivatives of thiazoles and pharmaceutical compositions containing these derivatives
EP1189895B8 (en)	2005-11-09	Thiazole and oxazole derivatives and their pharmaceutical use
DE60018205D1 (en)	2005-03-24	N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide als inhibitoren cyclinabhängiger kinasen
IL135176A0 (en)	2001-05-20	Benzothiazole derivatives and pharmaceutical compositions containing the same
IL135589A0 (en)	2001-05-20	Aminothiazole derivatives and pharmaceutical compositions containing the same
HUP0200155A3 (en)	2005-04-28	Thioamide derivatives, pharmaceutical compositions containing them and their use
IL159765A0 (en)	2004-06-20	Aryl substituted thiazolidinone derivatives and pharmaceutical compositions containing the same
HUP0103406A3 (en)	2002-11-28	1h-imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0401160A3 (en)	2008-01-28	2,4,5-trisubstituted thiazolyl derivatives having antiinflammatory activity, process for their preparation and pharmaceutical compositions containing them
AU2319100A (en)	2000-08-18	Amide derivatives and drug compositions
ATE240732T1 (de)	2003-06-15	Ziprasidonhaltige arzneimittel
HUP0102990A3 (en)	2002-09-30	Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
PL356484A1 (en)	2004-06-28	Thiazolyl amide derivatives
IL148517A0 (en)	2002-09-12	Heterocyclic compounds and pharmaceutical compositions containing the same
IL150077A0 (en)	2002-12-01	Heterocyclic compounds and pharmaceutical compositions containing the same
HU228254B1 (en)	2013-02-28	5-membered heteroaromatic compound and pharmaceutical compositions containing it
IL158523A0 (en)	2004-05-12	Epothilone derivatives and pharmaceutical compositions containing the same
CZ73995A3 (en)	1995-12-13	Thiazolidine and oxazolidine derivatives and pharmaceutical compositions containing thereof
IL202633A0 (en)	2010-06-30	Sulfonamide derivatives and pharmaceutical compositions containing the same
IL155196A0 (en)	2003-11-23	Benzamide derivatives and pharmaceutical compositions containing the same
IL149883A0 (en)	2002-11-10	Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0202520A3 (en)	2004-11-29	Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them